Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 112 articles:
HTML format



Single Articles


    July 2021
  1. FOIANI G, Guelfi G, Mandara MT
    MicroRNA Dysregulation in Canine Meningioma: RT-qPCR Analysis of Formalin-Fixed Paraffin-Embedded Samples.
    J Neuropathol Exp Neurol. 2021 Jul 17. pii: 6323287. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  2. LUCAS CG, Devine P, Solomon DA, Giannini C, et al
    Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    J Neuropathol Exp Neurol. 2021 Jun 12. pii: 6297520. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  3. KNUDSEN AM, Rudkjobing SJ, Sorensen MD, Dahlrot RH, et al
    Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276054. doi: 10.1093.
    PubMed     Abstract available


  4. HIRAKI T, Fukuoka K, Mori M, Arakawa Y, et al
    Application of Genome-Wide DNA Methylation Analysis to Differentiate a Case of Radiation-Induced Glioblastoma From Late-Relapsed Medulloblastoma.
    J Neuropathol Exp Neurol. 2021 May 15. pii: 6276056. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  5. GOSCHZIK T, Zur Muehlen A, Doerner E, Waha A, et al
    Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    J Neuropathol Exp Neurol. 2021;80:419-430.
    PubMed     Abstract available


  6. STEPHEN NIX J, Ida CM
    What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.
    J Neuropathol Exp Neurol. 2021 Apr 9. pii: 6219399. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  7. DAHL NA, Donson AM, Sanford B, Wang D, et al
    NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas.
    J Neuropathol Exp Neurol. 2021 Mar 22. pii: 6179633. doi: 10.1093.
    PubMed     Abstract available


  8. PHAM K, Maxwell MJ, Sweeney H, Alt J, et al
    Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    J Neuropathol Exp Neurol. 2021 Mar 13. pii: 6169464. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  9. SMITH MJ, Pathmanaban ON, Coope DJ, King AT, et al
    Comment on: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:289-290.
    PubMed    


  10. FONKEM E, Peng S, Berens M, Mukherjee S, et al
    Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021;80:290-291.
    PubMed    


  11. PRYZBYLSKI AL, Kollmeyer TM, Praska CE, Raghunathan A, et al
    Non-canonical IDH Mutation Frequency in IDH1-R132H-Negative Glioblastoma Patients Older Than 54 Years.
    J Neuropathol Exp Neurol. 2021 Feb 7. pii: 6130116. doi: 10.1093.
    PubMed    


  12. HEALY E
    Corrigendum to: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2021 Feb 4. pii: 6127560. doi: 10.1093.
    PubMed    


    January 2021
  13. MOVAHED-EZAZI M, Schwartz PJ, Zimmerman DL, Song X, et al
    Subependymal Giant Cell Astrocytoma in a 79-Year-Old Woman without Clinical Features of Tuberous Sclerosis: A Case Report.
    J Neuropathol Exp Neurol. 2021;80:199-201.
    PubMed    


  14. YEUNG J, Yaghoobi V, Aung TN, Vesely MD, et al
    Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas.
    J Neuropathol Exp Neurol. 2021 Jan 4. pii: 6061497. doi: 10.1093.
    PubMed     Abstract available


  15. HOLSTEN T, Lubieniecki F, Spohn M, Mynarek M, et al
    Detailed Clinical and Histopathological Description of 8 Cases of Molecularly Defined CNS Neuroblastomas.
    J Neuropathol Exp Neurol. 2021;80:52-59.
    PubMed     Abstract available


  16. BARRESI V, Simbolo M, Gessi M, Rossi S, et al
    Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
    J Neuropathol Exp Neurol. 2021;80:45-51.
    PubMed     Abstract available


  17. ARCHILLA I, Guerrero J, Reyes Figueroa LA, Capurro S, et al
    Intra-Axial Frontal Cyst with Ependymoma-Like Proliferation: Neuroectodermal or Neurenteric?
    J Neuropathol Exp Neurol. 2021;80:93-95.
    PubMed    


    December 2020
  18. WANG YH, Huang TL, Chen X, Yu SX, et al
    Glioma-Derived TSP2 Promotes Excitatory Synapse Formation and Results in Hyperexcitability in the Peritumoral Cortex of Glioma.
    J Neuropathol Exp Neurol. 2020 Dec 31. pii: 6056628. doi: 10.1093.
    PubMed     Abstract available


  19. MITANI Y, Fukuoka K, Mori M, Arakawa Y, et al
    Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
    J Neuropathol Exp Neurol. 2020 Dec 25. pii: 6047589. doi: 10.1093.
    PubMed    


  20. GOODMAN AL, Velazquez Vega JE, Rey Martinez LC, Brat DJ, et al
    Epithelioid Pituicytoma: Expanding the Morphologic Spectrum of a Rare Neoplasm.
    J Neuropathol Exp Neurol. 2020;79:1376-1378.
    PubMed    


    November 2020
  21. NATSUMEDA M, Miyahara H, Yoshimura J, Nakata S, et al
    GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma.
    J Neuropathol Exp Neurol. 2020 Nov 29. pii: 6010620. doi: 10.1093.
    PubMed     Abstract available


  22. ALSAFWANI N, Alrjoub M, Djuric U, Gao A, et al
    Tumor-Infiltrating Lymphocytes Are Enriched in Nonhypoxic Glioblastoma Niches.
    J Neuropathol Exp Neurol. 2020 Nov 19. pii: 5992386. doi: 10.1093.
    PubMed    


  23. YAO K, Duan Z, Du Z, Fan X, et al
    PRKCA D463H Mutation in Chordoid Glioma of the Third Ventricle: A Cohort of 16 Cases, Including Two Cases Harboring BRAFV600E Mutation.
    J Neuropathol Exp Neurol. 2020;79:1183-1192.
    PubMed     Abstract available


  24. NAVALKELE P, Guzman M, Kirby A, Pinz H, et al
    Familial Pediatric Clear Cell Meningioma With Germline SMARCE1 Mutation in the United States.
    J Neuropathol Exp Neurol. 2020;79:1250-1252.
    PubMed    


  25. GILBERT AR, Yan L, McDougall CM
    Broadening the Age of Incidence of Intracranial Angiomatoid Fibrous Histiocytoma With EWSR1-CREM Fusion: A Case Report.
    J Neuropathol Exp Neurol. 2020;79:1244-1246.
    PubMed    


  26. SAN-MIGUEL T, Navarro L, Sanchez-Sendra B, Megias J, et al
    Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation.
    J Neuropathol Exp Neurol. 2020;79:1233-1238.
    PubMed     Abstract available


  27. ZHENG H, Baranova K, Song J, Yan L, et al
    Overexpression of Long Noncoding RNA HOTAIR Is a Unique Epigenetic Characteristic of Myxopapillary Ependymoma.
    J Neuropathol Exp Neurol. 2020;79:1193-1202.
    PubMed     Abstract available


    October 2020
  28. SALLE H, Durand K, Gantois C, Labrousse F, et al
    Myxoid Meningioma: First Report of a Rare Metaplastic Meningioma Variant in the Pineal Region.
    J Neuropathol Exp Neurol. 2020 Oct 17. pii: 5928920. doi: 10.1093.
    PubMed    


  29. RICHARDSON TE, Kumar A, Xing C, Hatanpaa KJ, et al
    Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma.
    J Neuropathol Exp Neurol. 2020;79:1031-1037.
    PubMed     Abstract available


  30. MORRIS M, Driscoll M, Henson JW, Cobbs C, et al
    Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    J Neuropathol Exp Neurol. 2020;79:1038-1043.
    PubMed     Abstract available


  31. GITTO L, Serinelli S, Galbraith K, Williams M, et al
    Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the Literature.
    J Neuropathol Exp Neurol. 2020;79:1044-1053.
    PubMed     Abstract available


    September 2020
  32. DAL COL P, Poncet D, Rivoirard R, Vassal F, et al
    Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
    J Neuropathol Exp Neurol. 2020;79:1011-1014.
    PubMed     Abstract available


    August 2020
  33. PETTERSON SA, Sorensen MD, Kristensen BW
    Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892401. doi: 10.1093.
    PubMed     Abstract available


  34. QI S, Liu Y, Wang C, Fan J, et al
    Membrane Structures Between Craniopharyngioma and the Third Ventricle Floor Based on the QST Classification and Its Significance: A Pathological Study.
    J Neuropathol Exp Neurol. 2020 Aug 13. pii: 5892406. doi: 10.1093.
    PubMed     Abstract available


  35. TANG K, Gardner S, Snuderl M
    The Role of Liquid Biopsies in Pediatric Brain Tumors.
    J Neuropathol Exp Neurol. 2020 Aug 7. pii: 5882050. doi: 10.1093.
    PubMed     Abstract available


  36. MIKKELSEN VE, Dai HY, Stensjoen AL, Berntsen EM, et al
    MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.
    J Neuropathol Exp Neurol. 2020;79:855-862.
    PubMed     Abstract available


  37. ZANAZZI G, Pendrick D, Lin CC, Higgins D, et al
    Pineal Region High-Grade Glioneuronal Tumor With a Novel ZBTB10-NTRK3 Fusion.
    J Neuropathol Exp Neurol. 2020;79:929-931.
    PubMed    


  38. TANG K, Kurland D, Vasudevaraja V, Serrano J, et al
    Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2020;79:880-890.
    PubMed     Abstract available


    July 2020
  39. FURUTA T, Sugita Y, Komaki S, Ohshima K, et al
    The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869580. doi: 10.1093.
    PubMed     Abstract available


  40. GALBRAITH K, Kumar A, Abdullah KG, Walker JM, et al
    Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869581. doi: 10.1093.
    PubMed     Abstract available


  41. HUIZER K, Zhu C, Chirifi I, Krist B, et al
    Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma.
    J Neuropathol Exp Neurol. 2020 Jul 10. pii: 5869578. doi: 10.1093.
    PubMed     Abstract available


  42. MORISAKO T, Shishido-Hara Y, Inaba T, Takeuchi H, et al
    Primary CNS CD45-Depleted T-Cell Lymphoma: The First Pathologically Confirmed Case.
    J Neuropathol Exp Neurol. 2020;79:817-820.
    PubMed    


  43. SHAHAB S, Rubens J, Kaur H, Sweeney H, et al
    MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
    J Neuropathol Exp Neurol. 2020;79:746-753.
    PubMed     Abstract available


    June 2020
  44. KAM KL, Appin CL, Mao Q, Ikegami S, et al
    Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas?
    J Neuropathol Exp Neurol. 2020 Jun 1. pii: 5850092. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  45. GAUCHOTTE G, Peyre M, Pouget C, Cazals-Hatem D, et al
    Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective Study.
    J Neuropathol Exp Neurol. 2020 May 24. pii: 5843545. doi: 10.1093.
    PubMed     Abstract available


  46. ZHU LY, Wu XY, Liu XD, Zheng DF, et al
    Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway.
    J Neuropathol Exp Neurol. 2020 May 17. pii: 5838430. doi: 10.1093.
    PubMed     Abstract available


  47. MUKHERJEE S, Stroberg E, Wang F, Morales L, et al
    SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
    J Neuropathol Exp Neurol. 2020;79:562-565.
    PubMed     Abstract available


  48. AHRENDSEN JT, Hsu N, Wolf Z, Bryke C, et al
    Multiple Whole Chromosomal Gains Define Angiomatous Meningiomas and Are Absent From the Tumor Vasculature.
    J Neuropathol Exp Neurol. 2020 May 1. pii: 5827861. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  49. FIORAVANZO A, Caffo M, Di Bonaventura R, Gardiman MP, et al
    A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas.
    J Neuropathol Exp Neurol. 2020 Mar 31. pii: 5814172. doi: 10.1093.
    PubMed     Abstract available


  50. NAKATA S, Price A, Eberhart C, Morris M, et al
    Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration.
    J Neuropathol Exp Neurol. 2020 Mar 17. pii: 5809104. doi: 10.1093.
    PubMed     Abstract available


  51. BALLESTER LY, Meis JM, Lazar AJ, Prabhu SS, et al
    Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion.
    J Neuropathol Exp Neurol. 2020;79:347-351.
    PubMed     Abstract available


  52. SALLE H, Pocard M, Lehmann-Che J, Bourthoumieu S, et al
    Development of a Novel Orthotopic Primary Human Chordoma Xenograft Model: A Relevant Support for Future Research on Chordoma.
    J Neuropathol Exp Neurol. 2020;79:314-324.
    PubMed     Abstract available


    February 2020
  53. BODOR C, Alpar D, Marosvari D, Galik B, et al
    Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma.
    J Neuropathol Exp Neurol. 2020;79:176-183.
    PubMed     Abstract available


    January 2020
  54. D'ARCY CE, Nobre LF, Arnaldo A, Ramaswamy V, et al
    Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    J Neuropathol Exp Neurol. 2020 Jan 30. pii: 5735424. doi: 10.1093.
    PubMed     Abstract available


  55. HEWER E, Phour J, Gutt-Will M, Schucht P, et al
    TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.
    J Neuropathol Exp Neurol. 2020 Jan 29. pii: 5740035. doi: 10.1093.
    PubMed     Abstract available


  56. HO CY, Bornhorst M, Almira-Suarez MI, Donev K, et al
    Clinicopathologic Features of Diencephalic Neuronal and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2020;79:67-73.
    PubMed     Abstract available


  57. KLEINSCHMIDT-DEMASTERS BK
    Pituitary Adenomas in Transgender Individuals?
    J Neuropathol Exp Neurol. 2020;79:62-66.
    PubMed     Abstract available


    December 2019
  58. MARTIN AM, Bell WR, Yuan M, Harris L, et al
    PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    J Neuropathol Exp Neurol. 2019 Dec 9. pii: 5670883. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  59. PI CASTRO D, Jose-Lopez R, Fernandez Flores F, Rabanal Prados RM, et al
    Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
    J Neuropathol Exp Neurol. 2019 Nov 11. pii: 5679984. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  60. RICHARDSON TE, Tang K, Vasudevaraja V, Serrano J, et al
    GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    J Neuropathol Exp Neurol. 2019 Sep 16. pii: 5593615. doi: 10.1093.
    PubMed     Abstract available


  61. CHKHEIDZE R, Cimino PJ, Hatanpaa KJ, White CL, et al
    Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
    J Neuropathol Exp Neurol. 2019 Sep 12. pii: 5582700. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  62. LEAL LF, Cavagna RO, Campanella NC, Mancano B, et al
    Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas.
    J Neuropathol Exp Neurol. 2019 Aug 12. pii: 5548001. doi: 10.1093.
    PubMed     Abstract available


  63. KESSLER R, Fleischer M, Springsguth C, Bigl M, et al
    Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).
    J Neuropathol Exp Neurol. 2019 Aug 1. pii: 5542689. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  64. ZHANG H, Qin D, Jiang Z, Zhang J, et al
    SNHG9/miR-199a-5p/Wnt2 Axis Regulates Cell Growth and Aerobic Glycolysis in Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Jul 23. pii: 5555858. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  65. ROY S, Agnihotri S, El Hallani S, Ernst WL, et al
    Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors.
    J Neuropathol Exp Neurol. 2019 Jun 10. pii: 5531629. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  66. DAHLROT RH, Larsen P, Boldt HB, Kreutzfeldt MS, et al
    Posttreatment Effect of MGMT Methylation Level on Glioblastoma Survival.
    J Neuropathol Exp Neurol. 2019 May 6. pii: 5486005. doi: 10.1093.
    PubMed     Abstract available


  67. KOMAKI S, Sugita Y, Furuta T, Yamada K, et al
    Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.
    J Neuropathol Exp Neurol. 2019;78:389-397.
    PubMed     Abstract available


  68. LEE S, Kambhampati M, Yadavilli S, Gordish-Dressman H, et al
    Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
    J Neuropathol Exp Neurol. 2019;78:380-388.
    PubMed     Abstract available


    April 2019
  69. RICHARDSON TE, Patel S, Serrano J, Sathe AA, et al
    Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.
    J Neuropathol Exp Neurol. 2019 Apr 29. pii: 5481410. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  70. LI M, Zeng L, Liu S, Dangelmajer S, et al
    Transforming Growth Factor-beta Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma.
    J Neuropathol Exp Neurol. 2019 Mar 12. pii: 5376675. doi: 10.1093.
    PubMed     Abstract available


  71. TREVISAN P, Graziadio C, Rodrigues DBK, Rosa RFM, et al
    Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.
    J Neuropathol Exp Neurol. 2019 Mar 6. pii: 5370415. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  72. TEGLASI V, Csury DT, Dezso K, Bugyik E, et al
    Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns.
    J Neuropathol Exp Neurol. 2019 Feb 28. pii: 5366830. doi: 10.1093.
    PubMed     Abstract available


  73. TORRE M, Meredith DM, Dubuc A, Solomon DA, et al
    Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    J Neuropathol Exp Neurol. 2019 Feb 9. pii: 5366829. doi: 10.1093.
    PubMed     Abstract available


  74. XU C, Mao L, Xiong J, Wen J, et al
    TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:172-180.
    PubMed     Abstract available


  75. AHN JS, Harrison W, Hughes E, McLendon RE, et al
    Intraventricular Pilocytic Astrocytoma With KIAA1549/BRAF Fusion Arising in a 44-Year Old.
    J Neuropathol Exp Neurol. 2019;78:187-190.
    PubMed     Abstract available


    January 2019
  76. PARILLA M, Kadri S, Patil SA, Fitzpatrick C, et al
    Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.
    J Neuropathol Exp Neurol. 2019 Jan 28. pii: 5303810. doi: 10.1093.
    PubMed     Abstract available


  77. BERTERO L, Dalla Dea G, Osella-Abate S, Botta C, et al
    Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.
    J Neuropathol Exp Neurol. 2019 Jan 25. pii: 5301682. doi: 10.1093.
    PubMed     Abstract available


  78. DAOUD EV, Wachsmann M, Richardson TE, Mella D, et al
    Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.
    J Neuropathol Exp Neurol. 2019;78:10-14.
    PubMed     Abstract available


  79. LIPP ES, Healy P, Austin A, Clark A, et al
    MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.
    J Neuropathol Exp Neurol. 2019;78:57-64.
    PubMed     Abstract available


    September 2018
  80. LIU Y, Qi ST, Wang CH, Pan J, et al
    Pathological Relationship Between Adamantinomatous Craniopharyngioma and Adjacent Structures Based on QST Classification.
    J Neuropathol Exp Neurol. 2018 Sep 14. pii: 5098259. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  81. KOEHLER JW, Miller AD, Miller CR, Porter B, et al
    A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
    J Neuropathol Exp Neurol. 2018 Aug 27. pii: 5103388. doi: 10.1093.
    PubMed     Abstract available


  82. CANTERO D, Rodriguez de Lope A, Moreno de la Presa R, Sepulveda JM, et al
    Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
    J Neuropathol Exp Neurol. 2018;77:710-716.
    PubMed     Abstract available


    June 2018
  83. THOMPSON EM, Brown M, Dobrikova E, Ramaswamy V, et al
    Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.
    J Neuropathol Exp Neurol. 2018 Jun 6. pii: 5033817. doi: 10.1093.
    PubMed     Abstract available


  84. CHENG YC, Tsao MJ, Chiu CY, Kan PC, et al
    Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin.
    J Neuropathol Exp Neurol. 2018;77:426-436.
    PubMed     Abstract available


    May 2018
  85. GIANTINI LARSEN A, Grannan BL, Lee CK, Koch MJ, et al
    Malignant Melanoma Metastatic to Oligodendroglioma: Case Report and Literature Review of Tumor-to-Tumor Metastasis to Gliomas.
    J Neuropathol Exp Neurol. 2018 May 8. pii: 4993991. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  86. FERGUSON SD, Zhou S, Huse JT, de Groot JF, et al
    Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
    J Neuropathol Exp Neurol. 2018 Apr 27. pii: 4989444. doi: 10.1093.
    PubMed     Abstract available


    February 2018
  87. DAOUD EV, Rajaram V, Cai C, Oberle RJ, et al
    Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
    J Neuropathol Exp Neurol. 2018 Feb 10. pii: 4851722. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  88. YAO ZG, Li WH, Hua F, Cheng HX, et al
    LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1alpha Expression.
    J Neuropathol Exp Neurol. 2017;76:1000-1007.
    PubMed     Abstract available


  89. ESCHBACHER JM, Georges JF, Belykh E, Yazdanabadi MI, et al
    Immediate Label-Free Ex Vivo Evaluation of Human Brain Tumor Biopsies With Confocal Reflectance Microscopy.
    J Neuropathol Exp Neurol. 2017;76:1008-1022.
    PubMed     Abstract available


    November 2017
  90. SHI QY, Feng X, Bao W, Ma J, et al
    MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
    J Neuropathol Exp Neurol. 2017;76:942-948.
    PubMed     Abstract available


    October 2017
  91. FOO ASC, Tan DTM, Tan CL, Sahm F, et al
    Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.
    J Neuropathol Exp Neurol. 2017 Oct 16. doi: 10.1093.
    PubMed     Abstract available


  92. AL-HAJRI A, Al-Mughairi S, Somani A, An S, et al
    Pathology-MRI Correlations in Diffuse Low-Grade Epilepsy Associated Tumors.
    J Neuropathol Exp Neurol. 2017 Oct 12. doi: 10.1093.
    PubMed     Abstract available


  93. HANNEN R, Hauswald M, Bartsch JW
    A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:838-847.
    PubMed     Abstract available


  94. FORSSTROM LM, Sumi K, Makinen MJ, Oh JE, et al
    Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.
    J Neuropathol Exp Neurol. 2017;76:848-853.
    PubMed     Abstract available


  95. RICHARDSON TE, Shen ZJ, Kanchwala M, Xing C, et al
    Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.
    J Neuropathol Exp Neurol. 2017;76:874-882.
    PubMed     Abstract available


    September 2017
  96. DONSON AM, Apps J, Griesinger AM, Amani V, et al
    Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017;76:779-788.
    PubMed     Abstract available


    August 2017
  97. SCHWEIZER Y, Meszaros Z, Jones DTW, Koelsche C, et al
    Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    J Neuropathol Exp Neurol. 2017;76:655-664.
    PubMed     Abstract available


  98. PRATT D, Pittaluga S, Palisoc M, Fetsch P, et al
    Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:697-708.
    PubMed     Abstract available


    July 2017
  99. RYALL S, Arnoldo A, Krishnatry R, Mistry M, et al
    Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    J Neuropathol Exp Neurol. 2017;76:562-570.
    PubMed     Abstract available


  100. AMANI V, Donson AM, Lummus SC, Prince EW, et al
    Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
    J Neuropathol Exp Neurol. 2017;76:595-604.
    PubMed     Abstract available


    May 2017
  101. BARRESI V, Caffo M
    Rhabdoid Meningioma: Grading and Prognostic Significance of This Uncommon Variant.
    J Neuropathol Exp Neurol. 2017;76:414-416.
    PubMed    


    April 2017
  102. BARRESI V, Lionti S, Valori L, Gallina G, et al
    Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?
    J Neuropathol Exp Neurol. 2017 Apr 17. doi: 10.1093.
    PubMed     Abstract available


  103. AMES H, Halushka MK, Rodriguez FJ
    miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
    J Neuropathol Exp Neurol. 2017;76:246-254.
    PubMed     Abstract available


    March 2017
  104. BOULAGNON-ROMBI C, Fleury C, Fichel C, Lefour S, et al
    Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.
    J Neuropathol Exp Neurol. 2017 Mar 14. doi: 10.1093.
    PubMed     Abstract available


  105. BALLESTER LY, Fuller GN, Powell SZ, Sulman EP, et al
    Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.
    J Neuropathol Exp Neurol. 2017;76:179-188.
    PubMed     Abstract available


  106. BRUNER JM, Louis DN, McLendon R, Rosenblum MK, et al
    The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.
    J Neuropathol Exp Neurol. 2017;76:189-194.
    PubMed     Abstract available


    January 2017
  107. ROBINSON C, Kleinschmidt-DeMasters BK
    IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.
    J Neuropathol Exp Neurol. 2017 Jan 21. pii: nlw112. doi: 10.1093.
    PubMed     Abstract available


  108. GOSCHZIK T, Gessi M, Dreschmann V, Gebhardt U, et al
    Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017 Jan 9. pii: nlw116. doi: 10.1093.
    PubMed     Abstract available


  109. ASSLABER M, Schauer S, Gogg-Kamerer M, Bernhart E, et al
    Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    J Neuropathol Exp Neurol. 2017;76:16-26.
    PubMed     Abstract available


  110. JAPP AS, Klein-Hitpass L, Denkhaus D, Pietsch T, et al
    OTX2 Defines a Subgroup of Atypical Teratoid Rhabdoid Tumors With Close Relationship to Choroid Plexus Tumors.
    J Neuropathol Exp Neurol. 2017;76:32-38.
    PubMed     Abstract available


    November 2016
  111. YUAN JX, Bafakih FF, Mandell JW, Horton BJ, et al
    Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Abstract available


  112. LING C, Pouget C, Rech F, Pflaum R, et al
    Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: